Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling ...

CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on ...

We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Pfizer is facing some revenue pressures due to some higher Medicare discounts. Read more to see why I upgrade PFE stock from ...

Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research ...

Pharma giant now looking for $7.7bn in annual savings by 2027 as it grapples with falling post-Covid sales and lack of new ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

"No country wants to have critical medicines produced ... helped bring significant capital back to the company. Tax cuts good, tariffs bad: Pfizer CEO Albert Bourla in Davos on Jan. 23 ...